ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Famar, a Greek contract manufacturing services firm, is buying Roche’s site in Leganés, Spain, effective July 1. The site produces solid-dosage-form drugs with highly potent active ingredients. With the acquisition comes a long-term agreement to supply products to Roche. Because the Leganés site is FDA-certified, Famar says, it will now be able to access the U.S. market. The firm has 11 other sites from which it provides drug and personal care ingredients.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter